This suite of mitochondrial measurements demonstrates: 1) the consequences of inappropriate AT1 activation on mitochondrial activity and succinate clearance in the early stages of insulin resistance and metabolic syndrome, and 2) the benefits of chronic AT1 blockade on ameliorating the glucose-induced impairments on mitochondrial function. This evidence concerns the gene AGTR1 and metabolic syndrome.